According to the latest unaudited financial results approved by the Board of Directors on August 14, 2026, Uniworth International reported a standalone net loss of ₹39.40 lakh and consolidated loss of ₹39.65 lakh for the quarter ended June 30, 2026. This represents a slight widening from the standalone loss of ₹38.81 lakh and consolidated loss of ₹38.81 lakh recorded in the corresponding quarter of FY25. The company's business activities have been suspended for a long duration, resulting in nil income from operations for both standalone and consolidated entities. The results were filed with BSE on August 14, 2026, in compliance with SEBI regulations, with statutory auditors providing a limited review report.
As disclosed in the latest financial results, Uniworth International reported no sales during the quarter ended June 30, 2026, which was also the case for the corresponding quarter of the previous financial year. This indicates that the company has not generated any revenue from its operations during Q1 FY27, contributing to the reported net losses. With no operational revenue generated, the company's expenses were limited to statutory and administrative overheads.
The auditor's review report highlights significant balance sheet concerns, including unprovided trade receivables of ₹3,010.57 lakh and other financial assets of ₹227.73 lakh. No interest provision was made for borrowings from Punjab National Bank, Indusind Bank, and HSBC Bank, although simple interest provisions were recorded for borrowings from Centurion Bank and Punjab & Sind Bank. The company has not recognized deferred tax assets due to consistent losses and uncertainty regarding future profits. Additionally, applications have been filed with the Reserve Bank of India for the extension or set-off of certain overdue bills.
According to the detailed financial data, standalone total expenses rose marginally to ₹39.40 lakh from ₹38.81 lakh in Q1 FY25. Finance costs accounted for ₹38.25 lakh of these expenses in both standalone and consolidated figures. The consolidated expenses totaled ₹39.65 lakh, including a minor contribution from subsidiary Uniworth Biotech Limited, which reported a net loss of ₹0.25 lakh and nil revenue. The consolidated loss attributable to owners of the parent was ₹39.10 lakh.
